内容

目次

SECTION 1 HISTORICAL ASPECTS 1. Early Description and Key Contributionsto Understanding Non-Hodgkin's Lymphomas 2. Development of theHistopathologic Classifications of Lymphomas 3. The History of Chemotherapyof Lymphomas and Description of Early Trials 4. The History of RadiationTherapy of Lymphomas and Description of Early Trials SECTION 2 ETIOLOGY ANDEPIDEMIOLOGY 5. Overview of the Etiology and Epidemiology of Lymphoma 6.Lymphoma and Abnormalities of the Immune System 7. Lymphoma as an InfectiousDisease SECTION 3 BIOLOGY AND PATHOLOGY 8. Development and FunctionalBiology of B Lymphocytes 9. Developmental and Functional Biology of TLymphocytes 10. The REAL and WHO Classifications of Lymphoid Neoplasms 11.Immunophenotyping in Lymphoma Diagnosis and Classification 12. Lymphokinesand Cytokines in Lymphoma 13. Cytogenetics of Lymphoma 14. Molecular Geneticsof Lymphoma 15. The Relationship Between Non-Hodgkin's Lymphomas andHodgkin's Disease SECTION IV. STAGING AND INITIAL EVALUATION 16. DiagnosticProcedures 17. Initial Evaluation: Staging and Prognostic Factors 18.Diagnostic Radiology 19. Nuclear Medicine SECTION V. TREATMENT PRINICPLES ANDTECHNIQUES 20. Principles of Radiation Therapy 21. Principles ofChemotherapy and Combined Modality Therapy 22. Biologic Therapy 23.Principles of High Dose Therapy SECTION VI. PATHOLOGY, BIOLOGY, CLINICALEVALUATION AND SELECTION OF TREATMENT 24. Small B-LymphocyticLymphomas/Chronic Lymphocytic Leukemia, B-cell Prolymphocytic Leukemia 25.Lymphoplasmacytoid Lymphoma/Waldenstrom's Macroglobulinemia 26. SplenicMarginal Zone Lymphoma 27. T-cell Large Granular Lymphoproliferative Disease28. HTLV 1-Associated Adult T-cell Lymphoma/Leukemia 29. Mycosis Fungoides30. Cutaneous B-cell Lymphomas 31. CD30+ Cutaneous LymphoproliferativeDisease (ALCL and Lymphomatoid Papulosis 32. Extranodal Marginal Zone/MALTLymphoma 33. Nodal Marginal Zone/MALT Lymphoma 34. Follicular Lymphoma 35.Mantle Cell Lymphoma 36. Diffuse Large B-cell Lymphoma 37. PrimaryMediastinal Large B-cell Lymphoma 38. T-cell Anaplastic Large Cell Lymphoma39. Mature Nodal and Extra-nodal T-cell and NK-cell Lymphomas 40. Burkitt'sLymphoma 41. Precursor B and T-cell Lymphoblastic Lymphoma 42. Plasma CellNeoplasms: Multiple Myeloma and Plasmacytoma SECTION VII. LATE EFFECTS 43.Second Tumors 44. Late Effects of Treatment After Lymphoma 45. Assessing theQuality of Life in Patients with Lymphoma: Instruments and Clinical TrialsSECTION VIII. SPECIAL TOPICS 46. Management of Lymphoma in Children 47.Management of Lymphoma in the Elderly 48. Management of Lymphoma DuringPregnancy 49. Management of HIV Related Lymphoma 50. Diagnosis and Managementof Post-Transplant and Other Iatrogenic Immune DeficiencyLymphoproliferative Disorders 51. Management of CSN Lymphoma 52. MetabolicDisorders Associated with Lymphoma 53. Diagnosis and Management ofLymphoproliferative Disorders that can Mimic Lymphoma 54. Unique Aspects ofExtranodal Lymphoma